Potent and selective mediators of cholesterol efflux
Patent
·
OSTI ID:1174197
The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., Apo AI and Apo E), and having high selectivity for ABAC1 that parallels that of full-length apolipoproteins. The invention also provides compositions comprising such polypeptides, methods of identifying, screening and synthesizing such polypeptides, and methods of treating, preventing or diagnosing diseases and disorders associated with dyslipidemia, hypercholesterolemia and inflammation.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-05CH11231
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 8,987,192
- Application Number:
- 12/519,116
- OSTI ID:
- 1174197
- Resource Relation:
- Patent File Date: 2007 Dec 13
- Country of Publication:
- United States
- Language:
- English
Similar Records
Peptide mediators of cholesterol efflux
Peptides having reduced toxicity that stimulate cholesterol efflux
Peptides having reduced toxicity that stimulate cholesterol efflux
Patent
·
Tue Apr 09 00:00:00 EDT 2013
·
OSTI ID:1174197
Peptides having reduced toxicity that stimulate cholesterol efflux
Patent
·
Tue Sep 15 00:00:00 EDT 2020
·
OSTI ID:1174197
Peptides having reduced toxicity that stimulate cholesterol efflux
Patent
·
Tue Sep 06 00:00:00 EDT 2022
·
OSTI ID:1174197